Recurrence of rectal cancer on the pelvic sidewall after lateral lymph node dissection

• Published in: International journal of colorectal disease Vol. 39; no. 1; p. 80
• Main Authors: Takao, Misato, Kawai, Kazushige, Nakano, Daisuke, Dejima, Akira, Nakamori, Sakiko, Natsume, Soichiro, Ise, Ichiro, Kato, Hiroki, Yamaguchi, Tatsuro
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 28.05.2024
• Subjects: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Gastroenterology; Hepatology; Humans; Internal Medicine; Lymph Node Excision; Lymphatic Metastasis; Male; Medicine; Medicine & Public Health; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local - pathology; Pelvis - pathology; Pelvis - surgery; Proctology; Rectal Neoplasms - pathology; Rectal Neoplasms - surgery; Retrospective Studies; Risk Factors; Surgery; Lateral lymph nodes; Recurrence; Rectal cancer; Local recurrence
• ISSN: 1432-1262; 0179-1958; 1432-1262
• DOI: 10.1007/s00384-024-04650-7

Purpose Although lateral lymph node dissection has been performed to prevent lateral pelvic recurrence in locally advanced lower rectal cancer, the incidence of lateral pelvic recurrence after this procedure has not been investigated. Therefore, this study aimed to investigate the long-term outcomes of patients who underwent lateral pelvic lymph node dissection, with a particular focus on recurrence patterns. Methods This was a retrospective study conducted at a single high-volume cancer center in Japan. A total of 493 consecutive patients with stage II-III rectal cancer who underwent lateral lymph node dissection between January 2005 and August 2022 were included. The primary outcome measures included patterns of recurrence, overall survival, and relapse-free survival. Patterns of recurrence were categorized as lateral or central pelvic. Results Among patients who underwent lateral lymph node dissection, 18.1% had pathologically positive lateral lymph node metastasis. Lateral pelvic recurrence occurred in 5.5% of patients after surgery. Multivariate analysis identified age > 75 years, lateral lymph node metastasis, and adjuvant chemotherapy as independent risk factors for lateral pelvic recurrence. Evaluation of the recurrence rate by dissection area revealed approximately 1% of recurrences in each area after dissection. Conclusion We demonstrated the prognostic outcome and limitations of lateral lymph node dissection for patients with advanced lower rectal cancer, focusing on the incidence of recurrence in the lateral area after the dissection. Our study emphasizes the clinical importance of lateral lymph node dissection, which is an essential technique that surgeons should acquire.